“LMB spin-out company, Heptares Therapeutics, have entered a four-year collaboration with AstraZeneca on the development of new drugs targeting proteins.” More…
Home > LMB In The News > Heptares and AstraZeneca collaborate on drug development
MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.